A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials.
<h4>Background</h4>When rates of uptake of other drugs differ between treatment arms in long-term trials, the true benefit or harm of the treatment may be underestimated. Methods to allow for such contamination have often been limited by failing to preserve the randomization comparisons....
Guardado en:
Autores principales: | John Simes, Merryn Voysey, Rachel O'Connell, Paul Glasziou, James D Best, Russell Scott, Christopher Pardy, Karen Byth, David R Sullivan, Christian Ehnholm, Anthony Keech, FIELD Study Investigators |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cb9474b245145e6887b5c789122e9ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
por: Andrzej S. Januszewski, et al.
Publicado: (2021) -
Decisions are expedited through multiple neural adjustments spanning the sensorimotor hierarchy
por: Natalie A. Steinemann, et al.
Publicado: (2018) -
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS.
por: Douglas S Goodin, et al.
Publicado: (2011) -
How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
por: Katherine D. Crew, et al.
Publicado: (2017) -
Enhancing NO3- supply confers NaCl tolerance by adjusting Cl- uptake and transport in G. max & G. soja
por: Guo,J.S., et al.
Publicado: (2017)